Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution - Archive ouverte HAL Access content directly
Journal Articles Molecular Diagnosis and Therapy Year : 2020

Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution

(1, 2)
1
2

Abstract

This opinion article discusses the increasing attention paid to the role of activating damage-associated molecular patterns (DAMPs) in initiation of inflammatory diseases and suppressing/inhibiting DAMPs (SAMPs) in resolution of inflammatory diseases and, consequently, to the future roles of these novel biomarkers as therapeutic targets and therapeutics. Since controlled production of DAMPs and SAMPs is needed to achieve full homeostatic restoration and repair from tissue injury, only their pathological, not their homeostatic, concentrations should be therapeutically tackled. Therefore, distinct caveats are proposed regarding choosing DAMPs and SAMPs for therapeutic purposes. For example, we discuss the need to a priori identify and define a context-dependent "homeostatic DAMP:SAMP ratio" in each case and a "homeostatic window" of DAMP and SAMP concentrations to guarantee a safe treatment modality to patients. Finally, a few clinical examples of how DAMPs and SAMPs might be used as therapeutic targets or therapeutics in the future are discussed, including inhibition of DAMPs in hyperinflammatory processes (e.g., systemic inflammatory response syndrome, as currently observed in Covid-19), administration of SAMPs in chronic inflammatory diseases, inhibition of SAMPs in hyperresolving processes (e.g., compensatory anti-inflammatory response syndrome), and administration/induction of DAMPs in vaccination procedures and anti-cancer therapy.

Dates and versions

inserm-02548282 , version 1 (20-04-2020)

Identifiers

Cite

Walter Gottlieb Land. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution. Molecular Diagnosis and Therapy, 2020, ⟨10.1007/s40291-020-00460-z⟩. ⟨inserm-02548282⟩

Collections

INSERM SITE-ALSACE
66 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More